Omnicell (OMCL) Investor Presentation summary

Strategic vision and business model

• Focused on enabling the Autonomous Pharmacy transformation, aiming for zero medication errors, waste, and full regulatory compliance across care settings.

• Strategy centers on connecting health networks, disrupting pharmacy care with innovation, and expanding where care is delivered.

• Delivers outcomes-centric solutions combining robotics, smart devices, software, expert services, and analytics to optimize clinical and business results.

• Strong emphasis on recurring revenue through SaaS and Expert Services, targeting 22% of total revenue in 2025.

• Maintains a robust balance sheet to support growth and transformation to a subscription-based business model.

Product and service innovation

• Launched XT Amplify and Central Med Automation Service in 2024 to enhance efficiency, reduce errors, and centralize medication management.

• OmniSphere, a next-generation cloud-native platform, integrates robotics and smart devices for secure, data-driven medication management.

• Product suite covers points of care, central pharmacy, IV room, specialty pharmacy, ambulatory care, and medication adherence.

• SaaS and Expert Services provide recurring revenue across all care settings, leveraging robotics, software, and analytics.

• Solutions designed to address operational and economic challenges, such as reducing errors, waste, and compliance costs.

Financial performance and guidance

• Q3 2025 total revenue reached $311 million, with a non-GAAP gross margin of 44.2% and non-GAAP EBITDA of $41 million.

• Annual recurring revenue as of 12/31/2024 was $580 million, with a product backlog of $647 million.

• 2025 total revenue guidance is $1.177–$1.187 billion, with recurring revenue expected to comprise 56% of the total.

• SaaS and Expert Services projected to account for 22% of total revenue in 2025, up from 6% in 2020.

• New metrics for 2025 include product bookings (connected devices and software licenses) and annual recurring revenue (SaaS, technical services, consumables).